Meta tags:
keywords=capital, founds, multi-stage, provide, funds, scales, companies, healthcare, planetary, health, build, diligence, hands-on, operational, healthier;
description=RA Capital is an evidence-based, multi-stage healthcare and planetary health investor and company builder inventing a healthier future.;

Headings (most frequently used words):

the, we, in, and, of, to, health, investing, drug, biotech, evidence, planetary, into, value, china, why, too, from, enterprise, are, all, about, healthcare, re, hands, on, analytical, nerds, get, details, help, companies, solve, problems, news, insights, invest, grow, co, create, parabilis, zolucatetide, societal, that, wasn, supposed, exist, fermenting, change, where, biology, wins, biomanufacturing, scales, next, ra, capital, work, personal, viewpoint, paradox, protectionism, walling, off, weakens, america, it, is, never, early, or, late, tell, your, story, infectious, positivity, mario, barro, move, for, joy, let, reinvent, boards, ocean, blind, spot, better, forecasts, start, beneath, surface, march, madness, efficient, compute, takes, crown, role, insurance, rare, disease, funding, based, company, building, turning, ideas, enterprises,

Text of the page (most frequently used words):
the (105), and (65), fund (44), capital (43), for (21), nexus (20), health (15), #planetary (14), performance (14), not (14), from (12), into (11), returns (11), with (11), biotech (11), all (10), healthcare (10), companies (10), any (10), 2025 (9), 500 (9), investment (9), are (8), our (8), science (8), finance (8), based (7), your (7), managed (6), management (6), international (6), together (6), will (6), that (6), private (6), fees (6), securities (6), invest (6), company (6), work (6), aum (5), funds (5), were (5), investments (5), has (5), market (5), index (5), ibb (5), website (5), policy (5), help (5), team (5), evidence (5), news (5), overview (5), december (4), firm (4), including (4), account (4), iii (4), value (4), may (4), offshore (4), limited (4), partner (4), investor (4), expenses (4), time (4), information (4), future (4), references (4), financings (4), this (4), get (4), investing (4), hands (4), separately (3), represents (3), october (3), have (3), differ (3), 2004 (3), illustrated (3), fully (3), other (3), results (3), actual (3), investors (3), prior (3), such (3), weighted (3), subject (3), change (3), volatility (3), materially (3), only (3), growth (3), provide (3), services (3), views (3), you (3), where (3), insights (3), form (3), startup (3), next (3), knowledge (3), drug (3), culture (3), about (3), portfolio (3), net (2), commitments (2), additional (2), closings (2), upon (2), positions (2), been (2), unaudited (2), figures (2), period (2), due (2), activity (2), different (2), inception (2), represent (2), assume (2), new (2), issues (2), participating (2), vary (2), conditions (2), reasons (2), well (2), costs (2), financial (2), nasdaq (2), biotechnology (2), free (2), designed (2), leading (2), which (2), addition (2), appropriate (2), dividends (2), does (2), exception (2), available (2), result (2), should (2), reference (2), through (2), development (2), seed (2), stage (2), purposes (2), contained (2), advice (2), expressed (2), taken (2), security (2), circumstances (2), written (2), content (2), working (2), transform (2), can (2), contact (2), read (2), more (2), ideas (2), impact (2), raven (2), incubator (2), since (2), turning (2), funding (2), right (2), support (2), techatlas (2), engine (2), create (2), rapport (2), events (2), why (2), let (2), cidara (2), therapeutics (2), too (2), china (2), scales (2), breakthrough (2), analytical (2), nerds (2), details (2), solve (2), problems (2), healthier (2), menu (2), breakdown, approximate, includes, accounts, collectively, estimated, asset, plus, uncalled, except, still, actively, raising, reflects, received, updated, liquid, transferred, april, 2021, remain, active, until, illiquid, legacy, exited, final, timing, closing, cycle, was, its, feeder, ltd, commenced, operations, july, 2006, estimates, eligible, participated, reflect, payment, allocation, expense, higher, than, had, deducted, depend, level, exposure, participation, paid, changed, master, stated, sentence, differences, taxes, structural, between, annualized, past, necessarily, indicative, shown, compared, ishares, etf, total, return, november, seeks, track, composed, pharmaceutical, equities, listed, unmanaged, broad, float, adjusted, capitalization, measure, industries, economy, segment, equity, universe, holdings, comprise, selected, benchmarks, compare, but, rather, illustrative, general, trends, known, widely, recognized, indices, cannot, directly, assumes, reinvestment, interest, take, transaction, consideration, allocations, long, direct, use, leverage, accordingly, evaluating, invests, some, viewed, reflective, skill, abilities, respect, selection, individual, assessing, absolute, comparison, inherent, limitations, because, likely, experiences, possesses, risk, characteristics, calculated, basis, distributions, reinvested, january, aggregate, deloyed, stages, financing, rounds, initial, public, offering, ipo, venture, crossover, completed, while, issuer, remained, privately, held, informational, constitute, offer, advisory, nothing, constitutes, buy, sell, hold, endorsement, preparing, needs, objectives, particular, referenced, suitable, prepared, believed, reliable, makes, guarantees, their, accuracy, completeness, quickly, become, unreliable, various, changes, economic, accessing, agree, copy, reproduce, republish, upload, post, transmit, alter, distribute, way, materials, manner, inconsistent, offered, without, consent, 2026, linkedin, login, privacy, share, mission, idea, like, hear, email, hub, request, racap, com, touch, annual, report, inside, room, happens, featured, works, founders, translate, bold, vision, originated, created, unlocked, dozens, 2018, could, yours, enterprises, ipos, follow, every, milestone, develop, custom, platforms, further, faster, building, decisions, led, grounded, conviction, originate, within, proprietary, put, believe, best, chance, deliver, grow, how, role, insurance, rare, disease, march, madness, efficient, compute, takes, crown, ocean, blind, spot, better, forecasts, start, beneath, surface, move, joy, reinvent, boards, infectious, positivity, mario, barro, never, early, late, tell, story, paradox, protectionism, walling, off, weakens, america, personal, viewpoint, evodia, bio, fermenting, biology, wins, biomanufacturing, parabilis, zolucatetide, societal, wasn, supposed, exist, prev, ecosystem, assets, under, years, experience, members, 200, deployed, 650m, turned, lasting, approach, combines, deep, research, partnership, don, just, write, checks, roll, sleeves, founds, across, build, pair, scientific, diligence, multi, operational, insight, enterprise, found, advocacy, media, online, courses, university, opinions, board, tools, gateway, clinical, accelerator, blackbird, careers, advantage, join, teams, reimagine, futures, durable, access, expertise, accelerate, open, main, skip, home,

Text of the page (random words):
home ra capital skip to content menu open main menu let s work together fund your company access capital and expertise to accelerate growth form your startup turning breakthrough science into durable companies invest with ra capital evidence based investing in healthier futures work at ra capital join the teams working to reimagine health about overview our advantage team portfolio careers healthcare overview healthcare team healthcare portfolio planetary health overview planetary health team planetary health portfolio services overview raven healthcare incubator blackbird clinical development accelerator techatlas knowledge engine knowledge overview gateway board tools rapport ra capital insights opinions ra university free online courses news events all news ra capital news in the media advocacy contact more results result found from evidence to enterprise we are all about health ra capital founds funds and scales companies across healthcare and planetary health to build a healthier future for all we pair scientific diligence with multi stage capital and provide hands on operational insight and support fund your company invest with ra capital form your startup investing in healthcare healthcare investing in planetary health planetary health we re hands on analytical nerds we get into the details and help companies solve problems we re hands on analytical nerds we get into the details and help companies solve problems since 2004 ra capital has turned breakthrough science into lasting companies our evidence based approach combines deep research with hands on partnership we don t just write checks we roll up our sleeves about 650m capital deployed into private financings in 2025 1 200 team members 22 years of experience 2 14 4b assets under management as of 12 31 25 3 ra capital ecosystem news and insights prev next 07 17 26 parabilis zolucatetide the societal value of a drug that wasn t supposed to exist biotech science finance 07 14 26 fermenting change where biology wins and biomanufacturing scales next evodia bio planetary science finance 06 01 26 ra capital s work in china a personal viewpoint biotech culture 05 23 26 the paradox of biotech protectionism why walling off china biotech weakens america biotech policy finance 05 15 26 it is never too early or too late to tell your drug s value story cidara therapeutics biotech policy finance 05 01 26 the infectious positivity of mario barro cidara therapeutics biotech science culture 04 10 26 i move for joy let s reinvent biotech boards biotech culture finance 04 02 26 the ocean s blind spot why better forecasts start beneath the surface finance science planetary 03 31 26 planetary health march madness efficient compute takes the crown finance policy science planetary 03 11 26 the role of insurance in rare disease drug funding biotech finance policy news events rapport how we work we invest grow and co create evidence based investing our investment decisions are evidence based science led and grounded in conviction we originate from within techatlas ra capital s proprietary knowledge engine we put capital to work where we believe we have the best chance to create impact deliver returns and transform the future of health invest with ra capital company building from seed funding to ipos and follow on financings ra capital can provide the right capital at the right time to support growth through every milestone we develop custom platforms and services designed to help the companies we work with get further faster fund your company turning ideas into enterprises ra capital works to help founders translate bold ideas and vision into impact our raven healthcare incubator has originated co created and unlocked value with dozens of companies since 2018 could yours be next form your startup featured insights read our annual report biotech m a inside the room where it happens read more contact get in touch ra capital is working to transform the future of health if you share our mission and have a company or idea that can help we d like to hear from you email our hub team at request racap com privacy policy investor login linkedin 2026 ra capital management l p this website is for informational purposes only and does not constitute an offer to provide investment advisory or other services by ra capital management l p ra capital nothing contained on the website constitutes investment advice and the views expressed should not be taken as advice to buy sell or hold any security or as an endorsement of any security or company in preparing the information contained in this website ra capital has not taken into account the investment needs objectives and financial circumstances of any particular investor and investments and companies referenced may not be suitable for all investors any views expressed were prepared based upon information available and believed to be reliable at the time such views were written ra capital makes no guarantees as to their accuracy or completeness all information is subject to change and may quickly become unreliable for various reasons including changes in market conditions or economic circumstances by accessing this website you agree not to copy reproduce republish upload post transmit alter or distribute in any way content or materials from this website in any manner inconsistent with the purposes for which it is offered without the prior written consent of ra capital 1 for the period january 1 2025 through december 31 2025 represents aggregate capital deloyed by ra capital managed funds into private financings including investments in private companies at all stages of development and financing rounds prior to an initial public offering ipo including seed venture growth stage and crossover financings completed while the issuer remained privately held 2 the inception of the fund was on october 1 2004 and its offshore feeder fund ra capital healthcare international fund ltd the offshore fund commenced operations on july 1 2006 the returns illustrated for the fund represent estimates as of december 31 2025 and assume that a limited partner is eligible and has fully participated in all of the fund s private investments and new issues a fully participating investor net returns for the fund reflect the payment of management fees of 2 a performance allocation of 20 and other fees and expense and results in performance figures that are no higher than if the actual fees had been deducted the actual returns of a limited partner will vary from the returns illustrated for the fully participating investor and will depend on the limited partner s capital activity in the fund the level of exposure and participation in the fund s private investments and new issues actual fees and expenses paid by the limited partner and changed market conditions returns for investors in the offshore fund will vary from the illustrated returns for the master fund for the reasons stated in the prior sentence as well as due to differences in expenses such as taxes and structural costs between the fund and the offshore fund all annualized returns are time weighted returns returns for 2025 are based on unaudited financial information and are subject to change past performance is not necessarily indicative of future performance the performance shown is compared to the ishares nasdaq biotechnology etf healthcare index ibb hc and the s p 500 total return index s p 500 performance from inception of the fund on october 1 2004 to november 30 2025 the ibb hc seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the nasdaq an unmanaged broad based securities market index the s p 500 is a free float adjusted market capitalization weighted index designed to measure the performance of 500 leading companies in leading industries of the u s economy which represents a segment of the u s equity universe the volatility of the performance of the s p 500 is materially different from the volatility of the performance of the fund in addition the fund s holdings will materially differ from the positions that comprise the s p 500 the s p 500 and ibb hc were not selected to represent appropriate benchmarks to compare fund performance but rather to be illustrative of general securities market trends and the performance of a well known and widely recognized securities indices investors cannot invest directly in the s p 500 the s p 500 assumes reinvestment of dividends and interest if any and does not take transaction costs or fees and expenses into consideration the references are 1 not subject to management fees performance allocations or other expenses with the exception of the ibb 2 long only 3 not available for direct investment with the exception of the ibb 4 do not use leverage and 5 do not invest in private securities accordingly the references may not be appropriate for evaluating the performance of any investment fund managed by the firm the fund invests in only some of the securities in the references as a result the references should not be viewed as reflective of the firm s investment skill or abilities with respect to selection of individual securities for investment in addition in assessing the fund s absolute performance in comparison to any reference has inherent limitations because such reference likely experiences volatility or possesses risk characteristics that differ materially from the fund all returns are calculated on a time weighted basis and assume any dividends and distributions were reinvested 3 as of december 31 2025 the firm aum breakdown is approximate and includes all accounts managed by ra capital management l p including the fund the separately managed account ra capital nexus fund l p and ra capital nexus international fund l p together nexus fund i ra capital nexus fund ii l p and ra capital nexus international fund ii l p together nexus fund ii ra capital nexus fund iii l p and ra capital nexus international fund iii l p together nexus fund iii and ra capital nexus fund iv l p and ra capital nexus international fund iv l p together nexus fund iv and ra capital planetary health fund l p and ra capital planetary health international fund l p together planetary health aum of nexus fund i nexus fund ii nexus fund iii and nexus fund iv collectively the nexus funds and planetary health represents the estimated net asset value plus uncalled capital commitments as of december 31 2025 except for nexus iv nexus iv is still actively raising funds for additional closings nexus iv s aum reflects commitments received as of october 15 2025 and will be updated upon additional closings the liquid positions in the separately managed account were transferred into the fund on april 1 2021 the separately managed account will remain active until the illiquid legacy investments have been exited the firm aum is unaudited and may differ from final aum figures for the period due to the timing of capital activity and the closing cycle for the different funds